Efficacy of parecoxib for the treatment of postoperative shivering in patients undergoing general anesthesia
Not Applicable
- Conditions
- patients undergoing general anesthesia were recruited into the study
- Registration Number
- JPRN-UMIN000013226
- Lead Sponsor
- Department of Anaesthesiology, Southwest Hospital,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1, initial body temperature more than 38 centigrade or less than 36.5 centigrade; 2, hyperthyroidism, hypertension, diabetes mellitus, impaired renal or liver functions, endocrine or cardiopulmonary disease; 3, taking vasoactive or antidepressant drugs, receiving intraoperative blood or blood products transfusion; 4, known history of alcohol or substance abuse, or possible pregnancy;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method shivering grade
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie parecoxib's effect on postoperative shivering in general anesthesia patients?
How does parecoxib compare to standard anti-shivering agents like meperidine in postoperative care?
Are there specific biomarkers that predict patient response to parecoxib for postoperative shivering?
What are the potential adverse events associated with parecoxib use in postoperative settings and how are they managed?
What other COX-2 inhibitors or analgesic combinations show promise in managing postoperative shivering?